Anzeige
Mehr »
Samstag, 23.05.2026 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 899376 | ISIN: US5147661046 | Ticker-Symbol: LDE
Frankfurt
22.05.26 | 08:06
4,180 Euro
+8,85 % +0,340
1-Jahres-Chart
LIFECORE BIOMEDICAL INC Chart 1 Jahr
5-Tage-Chart
LIFECORE BIOMEDICAL INC 5-Tage-Chart
RealtimeGeldBriefZeit
4,2404,28011:49
4,1604,36022.05.

Aktuelle News zur LIFECORE BIOMEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
06.05.Lifecore Biomedical Q1 2026 Earnings Call Transcript1
06.05.Lifecore Biomedical GAAP EPS of $0.43 beats by $0.72, revenue of $23.2M misses by $2.76M1
LIFECORE BIOMEDICAL Aktie jetzt für 0€ handeln
06.05.Lifecore Biomedical, Inc.: Lifecore Biomedical Reports Financial Results for the First Quarter Ended March 31, 2026, and Provides Corporate Update98-- Reaffirms 2026 Guidance -- -- Signed Three New Commercial Site Transfer Programs in First Quarter 2026 -- -- Cost Containment Initiatives Continue to Drive Down Expenses -- Conference Call Today...
► Artikel lesen
06.05.LIFECORE BIOMEDICAL, INC. \DE\ - 10-Q, Quarterly Report-
06.05.LIFECORE BIOMEDICAL, INC. \DE\ - 8-K, Current Report-
27.04.Laughing Water Capital's Insights on Lifecore Biomedical (LFCR)1
22.04.Lifecore Biomedical, Inc.: Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)1
08.04.Lifecore Biomedical, Inc.: Lifecore Biomedical to Participate at 12th Annual American Biomanufacturing Summit1
26.03.Lifecore Biomedical, Inc.: Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)1
26.03.Lifecore Biomedical Inks Two New Agreements with Existing US Customer2
26.03.Lifecore signs two manufacturing deals with existing customer2
26.03.Lifecore Biomedical, Inc.: Lifecore Biomedical Signs Two New Agreements with Existing U.S. Biopharmaceutical Customer315-- Site Transfer Agreement for the Manufacture of Commercially Marketed Product -- -- Second Agreement Supports the Expansion of Product Commercially Manufactured at Lifecore to a New Delivery System...
► Artikel lesen
23.03.Lifecore Biomedical signs third site transfer deal in five months1
23.03.Lifecore Biomedical, Inc.: Lifecore Biomedical Signs Commercial Site Transfer Agreement with Leading Medical Aesthetics Company196-- Agreement for the Commercial Manufacture of Established, Approved Aesthetic Product -- -- Third Commercial Site Transfer Agreement Win in Five Months -- -- Program Expected to Generate Commercial...
► Artikel lesen
17.03.Lifecore Biomedical stellt strategische Neuausrichtung und Wachstumsziele vor4
17.03.Lifecore Stock Sinks As Delayed Launches Push Growth Further Out3
16.03.Lifecore targets 12% revenue CAGR through 2029 as midterm pipeline milestones shift3
16.03.Lifecore Biomedical: EPS verfehlt Schätzungen - Umsatz schlechter als erwartet4
16.03.Lifecore Biomedical GAAP EPS of -$0.16, revenue of $35.75M5
16.03.LIFECORE BIOMEDICAL, INC. \DE\ - 8-K, Current Report1
Weiter >>
42 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1